Markss HLC, a prominent healthcare firm in Sri Lanka, is celebrating its 20th anniversary this month. In a significant development, the company has formed a strategic alliance with George Steuart Health, the healthcare division of George Steuart & Company. This partnership focuses on the marketing and distribution of select products from Markss’s pharmaceutical range.
As part of this collaboration, George Steuart Health will utilize its extensive distribution network, seasoned sales team, and established connections with pharmacies, hospitals, and medical professionals to enhance the accessibility of Markss’s pharmaceutical offerings throughout Sri Lanka.
This alliance allows Markss to reinforce its commitment to the critical care sector, where it has built a robust presence. Additionally, it enables the company to continue investing in and accelerating the rollout of innovative healthcare solutions that are currently in development.
Submit Your Press Release
Get your company news, announcements, launches, appointments and events in front of a wider audience.
The partnership also marks the initiation of a more comprehensive strategic relationship between Markss and George Steuart Health, with both parties eager to seek further opportunities for collaboration and expansion in the future.
“Celebrating two decades of service to Sri Lanka’s healthcare sector, this collaboration with George Steuart Health represents a pivotal moment for us,” stated Mr. Rajiv Nanayakkara, Founder and Chairman of Markss. “By partnering with George Steuart Health to broaden the distribution of select pharmaceutical products, we aim to enhance accessibility for healthcare providers and patients nationwide. Furthermore, this partnership allows us to concentrate more on critical care and expedite the introduction of advanced healthcare solutions from our pipeline. We are excited about the potential to deepen our relationship with George Steuart Health as we progress.”
Mr. Erandajith Ranasinghe, Managing Director of George Steuart Health, expressed his enthusiasm about the partnership, stating, “We are delighted to join forces with Markss and facilitate the wider distribution of its selected pharmaceutical products through our established capabilities. This collaboration presents a valuable opportunity for both organizations to cultivate a strong and sustainable partnership, contributing to improved access to quality healthcare across Sri Lanka. We are eager to further develop this collaboration in the coming years.”
The formal agreement was signed last week by Mr. Sajeevan Wickramasinghe, who will assume the role of Managing Director of Markss on October 1, 2026, and Mr. Erandajith Ranasinghe, Managing Director of George Steuart Health.
Founded in 2006, Markss HLC is involved in the manufacturing, importation, distribution, and promotion of pharmaceuticals, nutraceuticals, biomedical, and surgical products. The company is a member of several prestigious organizations, including the Sri Lanka Chamber of the Pharmaceutical Industry and the National Chamber of Commerce of Sri Lanka.
George Steuart Health, established in 1986, operates as the healthcare arm of George Steuart & Company, which is Sri Lanka’s oldest mercantile establishment with a legacy spanning over 190 years. GS Health serves as a pharmaceutical and healthcare importer and distributor, representing more than 70 international healthcare manufacturers across 15 countries, with a comprehensive presence in pharmacies, hospitals, and other healthcare facilities nationwide, backed by a capable field workforce.
In attendance at the signing ceremony were key executives from both companies, including Thulitha J. (Finance Director, GS Health), Damian Silva (CCO, Markss), Sajeevan W. (CEO, Markss), Rajeev N. (Chairman, Markss), Sanjiva W. (Executive Director, GS Health), and Thushantha N. (Director, GS Health).
